title: Whole-cell NMDA-evoked current in suprachiasmatic neurones of the rat: modulation by extracellular calcium ions.
abstract: The action of N-methyl-D-aspartic acid (NMDA) on suprachiasmatic neurones was studied using whole-cell recordings in coronal hypothalamic slices of the rat. The location of the recorded neurones within the suprachiasmatic nucleus was ascertained by intracellular labelling with biocytin, followed by histological processing of the slice. Suprachiasmatic neurones had an input resistance of 780 +/- 20 M omega (mean +/- S.E.M.; n = 106). They were voltage-clamped at or near their resting membrane potential and their responsiveness to NMDA was tested by adding this compound to the perfusion solution. NMDA generated an inward current in about 85% of the neurones. At 50 microM, the average induced peak current was 30 +/- 10 pA (n = 32); at 100 microM, it was 50 +/- 10 pA (n = 12). The NMDA-induced current was reduced by D-2-amino-5-phosphopentanoic acid (D-AP5), and NMDA receptor antagonist, and was suppressed by MK-801, and NMDA channel blocker. Reducing the extracellular magnesium concentration from 1 to 0.01 mM caused a 2- to 3-fold increase in the amplitude of this current. Thus, suprachiasmatic neurones are endowed with functional NMDA receptor-channels, which may play a role in glutaminergic transmission in this nucleus. Decreasing the extracellular calcium concentration from 2 to 0.01 mM caused a 1.3- to 4.5-fold enhancement in the whole-cell NMDA current. This effect was probably not mediated by a change in the intracellular free calcium concentration. Indeed, loading suprachiasmatic neurones with 11 or 20 mM of the calcium chelator, 1,2-bis(2- aminophenoxy)ethane-N,N,N',N'-tetracetic acid (BAPTA) suppressed a calcium-dependent slowly decaying outward aftercurrent but did not affect the low-calcium-induced facilitation of the NMDA response. NMDA current-voltage relations were established in normal and low-calcium perfusion solutions. In the normal solution, the net current generated by NMDA contained a region of negative slope conductance and reversed in polarity at 7 +/- 2 mV. In the low-calcium solution, this current increased in amplitude in the region of negative slope conductance, whereas at more depolarized potentials it was not altered. The NMDA-induced current was fitted using the Boltzmann equation. The effect of a low-calcium solution could be modelled by shifting the activation of the NMDA-sensitive conductance in the negative direction, by about 17 mV. We conjecture that lowering external calcium can unmask negative surface charges located on or near the NMDA channel and that this, in turn, weakens the voltage-dependent block of the channel by magnesium. A voltage-dependent blockade of the NMDA channel by calcium, however, may be also contribute to this effect. This low-calcium-induced facilitation of the NMDA response could play a regulatory role by enhancing calcium influx through the NMDA channel in case of calcium depletion in its vicinity.
authors.affiliation: Department of Physiology, University Medical Centre, Geneva, Switzerland.
authors.forename: S
authors.initials: S
authors.lastname: Alberi
authors.forename: M
authors.initials: M
authors.lastname: Dubois-Dauphin
authors.forename: J J
authors.initials: JJ
authors.lastname: Dreifuss
authors.forename: M
authors.initials: M
authors.lastname: Raggenbass
mesh_terms: D000818:Animals; D002118:Calcium / Q000502:physiology*; D002614:Chelating Agents / Q000494:pharmacology; D004533:Egtazic Acid / Q000031:analogs & derivatives / Q000494:pharmacology; D018690:Excitatory Amino Acid Agonists / Q000494:pharmacology*; D005110:Extracellular Space / Q000187:drug effects / Q000378:metabolism; D066298:In Vitro Techniques; D015640:Ion Channel Gating / Q000187:drug effects; D007473:Ion Channels / Q000187:drug effects / Q000378:metabolism*; D008274:Magnesium / Q000502:physiology; D008297:Male; D008564:Membrane Potentials / Q000187:drug effects / Q000502:physiology; D016202:N-Methylaspartate / Q000494:pharmacology*; D009474:Neurons / Q000187:drug effects / Q000378:metabolism*; D018408:Patch-Clamp Techniques; D051381:Rats; D017207:Rats, Sprague-Dawley; D013493:Suprachiasmatic Nucleus / Q000187:drug effects / Q000378:metabolism*
chemical_list: D002614:Chelating Agents; D018690:Excitatory Amino Acid Agonists; D007473:Ion Channels; D004533:Egtazic Acid; D016202:N-Methylaspartate; D008274:Magnesium; C025603:1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid; D002118:Calcium